Location History:
- Newbury Park, CA (US) (2004 - 2006)
- Thousand Oaks, CA (US) (2000 - 2009)
Company Filing History:
Years Active: 2000-2009
Title: The Innovations of David L. Lacey
Introduction
David L. Lacey is a prominent inventor based in Thousand Oaks, California. He has made significant contributions to the field of biotechnology, particularly in the area of bone metabolism. With a total of 10 patents to his name, Lacey's work has had a profound impact on the treatment of bone diseases.
Latest Patents
Among his latest patents is the invention of osteoprotegerin, a novel secreted polypeptide that plays a crucial role in regulating bone metabolism. This invention includes nucleic acids encoding osteoprotegerin, polypeptides, recombinant vectors, and host cells for expression. Additionally, it encompasses antibodies that bind to osteoprotegerin and pharmaceutical compositions aimed at treating bone diseases characterized by increased resorption, such as osteoporosis. Another significant patent involves combination therapy for conditions leading to bone loss, which describes methods of treatment using osteoprotegerin in conjunction with various agents, including IL-1 inhibitors, TNF-α inhibitors, and serine protease inhibitors.
Career Highlights
David Lacey is currently associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to further develop his innovative ideas and contribute to advancements in medical treatments.
Collaborations
Lacey has collaborated with notable colleagues, including William James Boyle and Frank J. Calzone. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking therapies.
Conclusion
David L. Lacey's contributions to biotechnology, particularly in the field of bone metabolism, have led to significant advancements in the treatment of bone diseases. His innovative patents and collaborations continue to shape the future of medical science.